Searchable abstracts of presentations at key conferences in endocrinology

ea0015p244 | Pituitary | SFEBES2008

Discordant stimulated growth hormone (GH) responses in cranially irradiated adult cancer survivors may occur in the presence of normal GH status: compensated GH deficiency

Darzy Ken , Thorner Michael , Shalet Stephen

Context: We have previously demonstrated that, in cranially irradiated patients with normal peak GH responses to both the insulin tolerance test (ITT) and the growth hormone-releasing hormone plus arginine stimulation test (GHRH+AST), somatotroph reserve can be substantially reduced, while individual and overall spontaneous GH secretion remain entirely normal due presumably to a compensatory increase in hypothalamic stimulatory input within a partially damaged hypothalamic pit...

ea0021p292 | Pituitary | SFEBES2009

Circadian and pulsatile secretion of copeptin, an arginine vasopressin (AVP) marker, argues against a physiological role of AVP in cortisol release

Darzy Ken , Dixit Kashinath , Shalet Stephen , Morgenthaler Nils , Brabant Georg

Copeptin is a stable AVP marker and stoichiometrically released with AVP. It closely reflects changes in water balance. Its stimulation in severe stress has recently has been suggested for the early diagnosis of myocardial infarction but clear definition of the physiological variability is necessary. Here, we studied the pulsatile and circadian variation in healthy individuals and compared copeptin to cortisol rhythms.Copeptin levels were sampled every 2...

ea0069p34 | Poster Presentations | SFENCC2020

Radio-iodine treatment for thyrotoxicosis in unsuspected pregnancy

Lin Nyan Tun , Yin Yin , Joharatnam Jalini , Kaplan Felicity , Darzy Ken

Our endocrinology department had been looking after a patient with Graves’ disease since 2007. At this time, she was 17 years old (TSH <0.03 mIU/l, T4 62.6 pmol/l). Carbimazole was prescribed but she was non-compliant with medications and clinic appointments. Her background history included DiGeorge Syndrome (22q11 deletion) manifesting with a bicuspid aortic valve, primary hypoparathyroidism and chronic constipation. She was seen in October 2011 and carbimazole incre...

ea0065p98 | Bone and calcium | SFEBES2019

Audit into appropriate diagnostic investigation and MDT discussion prior to parathyroidectomy for primary hyperparathyroidism

Zac-Varghese Sagen , Cohen Ezme , Mochloulis George , Langroudi Babak , Rajaguru Kanchana , Viljoen Adie , Woods Angela , Joharatnam Jalini , Al-Sabbagh Samer , Darzy Ken , Kaplan Felicity , Winocour Peter

An audit of parathyroidectomies carried out at the East and North Herts Trust between 2010 and 2014 revealed a 25% failure rate following surgery. The audit revealed inappropriate pre-operative workup with regards to biochemistry and/or imaging in 40% of cases. In 2015, a parathyroid MDT was established. The aim of this was to ensure patients had appropriate investigation prior to referral for surgery. A Trust hyperparathyroidism pathway was written based on best practice and ...

ea0020p9 | Adrenal | ECE2009

Replicating the normal cortisol circadian rhythm using a formulation of modified-release hydrocortisone

Debono Miguel , Ghobadi Cyrus , Rostami-Hodjegan Amin , Huatan Hiep , Campbell Mike , Newell-Price John , Darzy Ken , Merke DeborahP , Arlt Wiebke , Ross Richard

Background: The adrenal glucocorticoid, cortisol, has a distinct circadian rhythm regulated by the brain’s central pacemaker. This cortisol rhythm acts as a secondary messenger to peripheral tissues and loss of the rhythm is associated with increased morbidity and mortality. This is a specific problem in adrenal insufficiency and congenital adrenal hyperplasia (CAH). Based on pharmacokinetic modelling we have developed a modified-release formulation of hydrocortisone (MR-...

ea0034p14 | Bone | SFEBES2014

Clinical studies of adaptor protein-2 sigma subunit mutations causing familial hypocalciuric hypercalcaemia type 3 reveal genotype–phenotype correlations and effectiveness of cinacalcet

Hannan Fadil , Rogers Angela , Howles Sarah , Cranston Treena , McKenna Malachi , Richardson Tristan , Babinsky Valerie , Reed Anita , Thakker Clare , Bockenhauer Detlef , Brown Rosalind , Cook Jacqueline , Darzy Ken , Ehtisham Sarah , Graham Una , Hulse Tony , Hunter Steven , Kumar Dhavendra , McKnight John , Morrison Patrick , Mughal Zulf , Pearce Simon , Scheers Isabelle , Wang Timothy , Whyte Michael , Nesbit M Andrew , Thakker Rajesh

Familial hypocalciuric hypercalcaemia (FHH) comprises three types: FHH1, FHH2, and FHH3, which are due to mutations of the calcium-sensing receptor (CaSR), G-protein α 11 subunit (Gα11), and adaptor protein-2 sigma subunit (AP2σ), respectively. The aims of this study were: to assess for genotype–phenotype correlations among the three reported FHH3-causing AP2σ mutations, which all involve the Arg15 residue, and comprise Arg15Cys, Arg15His, and Arg15Leu...

ea0034p15 | Bone | SFEBES2014

Identification of 12 adaptor protein-2 sigma 2 subunit mutations in familial hypocalciuric hypercalcaemia type 3 and expansion of phenotypic spectrum.

Rogers Angela , Hannan Fadil M , Howles Sarah A , Cranston Treena , Thakker Clare E , Bockenhauer Detlef , Brown Rosalind , Cook Jacqueline A , Darzy Ken , Ehtisham Sarah , Hulse Tony , Kumar Dhavendra , McKenna Malachi , McKnight John , Mughal Zulf , Pearce Simon H , Richardson Tristan , Scheers Isabelle , Wang Timothy , Nesbit M Andrew , Thakker Rajesh V

Familial hypocalciuric hypercalcaemia (FHH) is an autosomal dominant disorder characterized by hypercalcaemia and inappropriately low urinary calcium excretion, and is occasionally associated with acute pancreatitis. FHH can be classified into three types: FHH type 1, caused by loss-of-function mutations of the calcium-sensing receptor (CaSR), which accounts for >65% of cases; FHH type 2, due to loss-of-function mutations of the G-protein α 11 subunit (Gα11), of ...